Piperazine, 1-(4-acetylphenylsulfonyl)-4-methyl-, ID: C309271258
  NIST    18053106292D 1   1.00000     0.00000      
Copyright by the U.S. Sec. Commerce on behalf of U.S.A. All rights reserved.
 19 20  0     0  0              1 V2000
    0.0000    1.8825    0.0000 C   0  0  0  0  0  0           0  0  0
    0.4459    1.0404    0.0000 C   0  0  0  0  0  0           0  0  0
    8.4219    1.0404    0.0000 C   0  0  0  0  0  0           0  0  0
    7.4311    1.0404    0.0000 N   0  0  0  0  0  0           0  0  0
    3.4183    1.0404    0.0000 C   0  0  0  0  0  0           0  0  0
    4.4587    1.0404    0.0000 S   0  0  0  0  0  6           0  0  0
    2.9724    0.1486    0.0000 C   0  0  0  0  0  0           0  0  0
    2.9724    1.8825    0.0000 C   0  0  0  0  0  0           0  0  0
    6.9357    0.1486    0.0000 C   0  0  0  0  0  0           0  0  0
    5.9449    0.1486    0.0000 C   0  0  0  0  0  0           0  0  0
    6.9357    1.8825    0.0000 C   0  0  0  0  0  0           0  0  0
    5.9449    1.8825    0.0000 C   0  0  0  0  0  0           0  0  0
    1.9321    1.8825    0.0000 C   0  0  0  0  0  0           0  0  0
    1.4862    1.0404    0.0000 C   0  0  0  0  0  0           0  0  0
    5.4495    1.0404    0.0000 N   0  0  0  0  0  0           0  0  0
    1.9321    0.1486    0.0000 C   0  0  0  0  0  0           0  0  0
    0.0000    0.1486    0.0000 O   0  0  0  0  0  0           0  0  0
    4.4587    2.0312    0.0000 O   0  0  0  0  0  0           0  0  0
    4.4587    0.0000    0.0000 O   0  0  0  0  0  0           0  0  0
  1  2  1  0     0  0
  2 14  1  0     0  0
  2 17  2  0     0  0
  3  4  1  0     0  0
  4  9  1  0     0  0
 11  4  1  0     0  0
  5  6  1  0     0  0
  5  7  2  0     0  0
  8  5  1  0     0  0
  6 18  2  0     0  0
  6 19  2  0     0  0
  6 15  1  0     0  0
  7 16  1  0     0  0
 13  8  2  0     0  0
  9 10  1  0     0  0
 10 15  1  0     0  0
 12 11  1  0     0  0
 15 12  1  0     0  0
 14 13  1  0     0  0
 16 14  2  0     0  0
M  END
